Purpura fulminans: MRSA sepsis compounded by diclofenac
Journal of Pakistan Association of Dermatologists · 12.10.2023 · 33 (4) · 1780-1782
DOI: 10.66344/jpad.v33i4.2589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pakistan Association of Dermatologists, online erschienen am 12.10.2023. Verfasst von Mahym Mansoor und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Purpura fulminans is a rare, albeit a life-threatening emergency which has been reportedly triggered by infections, congenital disorders of protein C or S deficiencies, as well as drugs. Here we report a case of a previously healthy 17 year old male who developed purpura fulminans after fever, sore throat and then getting injection diclofenac. Blood cultures grew Staph. aureus. This case is the first to report two causative etiologies in a single patient.
Zitieren
APA
Mansoor, M., Saeed, W., Altaf, F., Hussain, I., & Khan, F. N. (2023). Purpura fulminans: MRSA sepsis compounded by diclofenac. Journal of Pakistan Association of Dermatologists, 33(4), 1780-1782. https://doi.org/10.66344/jpad.v33i4.2589
Vancouver
Mansoor M, Saeed W, Altaf F, Hussain I, Khan FN. Purpura fulminans: MRSA sepsis compounded by diclofenac. Journal of Pakistan Association of Dermatologists. 2023;33(4):1780-1782. doi:10.66344/jpad.v33i4.2589
BibTeX
@article{Mansoor2023,
author = {Mansoor, Mahym and Saeed, Wajieha and Altaf, Faria and Hussain, Ijaz and Khan, Farwa Nasir},
title = {Purpura fulminans: MRSA sepsis compounded by diclofenac},
journal = {Journal of Pakistan Association of Dermatologists},
year = {2023},
volume = {33},
number = {4},
pages = {1780--1782},
doi = {10.66344/jpad.v33i4.2589}
}
EUVIMED